Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

NeuroPace (NPCE) Operating Expenses (2020 - 2025)

NeuroPace (NPCE) has 6 years of Operating Expenses data on record, last reported at $22.3 million in Q4 2025.

  • For Q4 2025, Operating Expenses rose 12.62% year-over-year to $22.3 million; the TTM value through Dec 2025 reached $93.6 million, up 15.85%, while the annual FY2025 figure was $93.6 million, 15.85% up from the prior year.
  • Operating Expenses reached $22.3 million in Q4 2025 per NPCE's latest filing, down from $23.8 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $25.0 million in Q2 2025 and bottomed at $12.4 million in Q1 2021.
  • Average Operating Expenses over 5 years is $19.0 million, with a median of $18.7 million recorded in 2022.
  • The widest YoY moves for Operating Expenses: up 57.48% in 2021, down 1.18% in 2021.
  • A 5-year view of Operating Expenses shows it stood at $17.1 million in 2021, then rose by 9.19% to $18.7 million in 2022, then fell by 0.35% to $18.6 million in 2023, then rose by 6.69% to $19.8 million in 2024, then rose by 12.62% to $22.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Expenses were $22.3 million in Q4 2025, $23.8 million in Q3 2025, and $25.0 million in Q2 2025.